ADHD is a disorder that manifests in childhood with two categories of core symptoms: hyperactivity/impulsivity and inattention. The prevalence of ADHD in school-age children is estimated to be between 9 and 15 percent, making it one of the most common disorders of childhood.

Hyperactive and impulsive behaviors almost always occur together in young children. The predominantly hyperactive-impulsive subtype of ADHD is characterized by the inability to sit still or inhibit behavior; symptoms typically are observed by the time the child reaches four years of age and increase during the next three to four years, peaking in severity when the child is seven to eight years of age. The predominantly inattentive subtype of ADHD is characterized by reduced ability to focus attention and reduced speed of cognitive processing and responding. Children with the inattentive subtype often are described as having a sluggish cognitive tempo and frequently appear to be daydreaming or "off task".

What are the most troubling symptoms seen in pediatric ADHD patients?

How willing are you to try newly approved innovative therapies instead of long-standing standard of care therapies?

_{Source:
• Wolraich, Mark L et al. “Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.” Pediatrics vol. 144,4 (2019): e20192528. doi:10.1542/peds.2019-2528}

ADHD is a disorder that manifests in childhood with two categories of core symptoms: hyperactivity/impulsivity and inattention. The prevalence of ADHD in school-age children is estimated to be between 9 and 15 percent, making it one of the most common disorders of childhood.



Hyperactive and impulsive behaviors almost always occur together in young children. The predominantly hyperactive-impulsive subtype of ADHD is characterized by the inability to sit still or inhibit behavior; symptoms typically are observed by the time the child reaches four years of age and increase during the next three to four years, peaking in severity when the child is seven to eight years of age. The predominantly inattentive subtype of ADHD is characterized by reduced ability to focus attention and reduced speed of cognitive processing and responding. Children with the inattentive subtype often are described as having a sluggish cognitive tempo and frequently appear to be daydreaming or "off task".



What are the most troubling symptoms seen in pediatric ADHD patients?



How willing are you to try newly approved innovative therapies instead of long-standing standard of care therapies?



<sub>Source:

• Wolraich, Mark L et al. “Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.” Pediatrics vol. 144,4 (2019): e20192528. doi:10.1542/peds.2019-2528</sub>

ADHD is a disorder that manifests in childhood with two categories of core symptoms: hyperactivity/impulsivity and inattention. The prevalence of ADHD in school-age children is estimated to be between 9 and 15 percent, making it one of the most common disorders of childhood.



Hyperactive and impulsive behaviors almost always occur together in young children. The predominantly hyperactive-impulsive subtype of ADHD is characterized by the inability to sit still or inhibit behavior; symptoms typically are observed by the time the child reaches four years of age and increase during the next three to four years, peaking in severity when the child is seven to eight years of age. The predominantly inattentive subtype of ADHD is characterized by reduced ability to focus attention and reduced speed of cognitive processing and responding. Children with the inattentive subtype often are described as having a sluggish cognitive tempo and frequently appear to be daydreaming or "off task".



What are the most troubling symptoms seen in pediatric ADHD patients?



How willing are you to try newly approved innovative therapies instead of long-standing standard of care therapies?



<sub>Source:

• Wolraich, Mark L et al. “Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.” Pediatrics vol. 144,4 (2019): e20192528. doi:10.1542/peds.2019-2528</sub>